Search

Search Constraints

You searched for: Author/Creator Held, Gerhard

Search Results

1. Elevated serum free light chains do not predict outcome of elderly patients with aggressive CD20+ B‐cell lymphomas. (27th June 2014)

2. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Issue 10216 (21st December 2019)

3. High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL‐GITMO. (9th July 2018)

4. Identification of a miRNA based model to detect prognostic subgroups in patients with aggressive B-cell lymphoma. Issue 5 (16th April 2021)

6. KIR2DS1–HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials. Issue 2 (February 2022)

7. Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group. Issue 1 (13th July 2020)

8. Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group. Issue 1 (13th July 2020)

9. Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group. Issue 1 (13th July 2020)

10. Modeling the TTL at Continental Scale for a Wet Season: An Evaluation of the BRAMS Mesoscale Model Using TRO‐Pico Campaign, and Measurements From Airborne and Spaceborne Sensors. Issue 5 (6th March 2018)